Biotech News

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Sotera Health (SHC)Sotera HealthEarnings

Q1 2026 net revenues increased 10.0%, or 6.5% on a co nstant currenc y basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 Q1 2026 Adjusted EBITDA ( 1) increased 10.5%, or 6.9% on a

Related news

Sotera Health

Healthcare Sterilization Infrastructure Sotera Health provides sterilization, laboratory testing and advisory services that support the safety and regulatory compliance of medical devices, pharmaceuticals and other healthcare products. Its businesses operate at critical points between product manufacturing and release to...

Recent company news

Stock data

Close
18.91 USD
Market cap
4.28B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States